Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Effects of the Direct Acting Antiviral Agent Boceprevir on the Pharmacokinetics of Maraviroc in Healthy Volunteers

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2013 by Centre hospitalier de l'Université de Montréal (CHUM).
Recruitment status was:  Recruiting
Sponsor:
Collaborators:
Université de Montréal
McGill University Health Center
Toronto General Hospital
Information provided by (Responsible Party):
Nancy Sheehan, Centre hospitalier de l'Université de Montréal (CHUM)
ClinicalTrials.gov Identifier:
NCT01627717
First received: June 21, 2012
Last updated: May 30, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2014
  Estimated Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)